In vitro and in vivo performance of amorphous solid dispersions of ursolic acid as a function of polymer type and excipient addition
Journal of Pharmacy and Pharmacology · 02.12.2024 · 76 (12) · 1584-1598
DOI: 10.1093/jpp/rgae125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 11.10.2024. Verfasst von Tingting Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, People's Republic of China. Hauptthemen laut MEDLINE: Triterpenes, Excipients, Polymers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Objectives
The objective of this research was to enhance the bioavailability of ursolic acid (UA) by preparing multielement amorphous solid dispersion (ASD) systems comprising excipients.
Methods
The ASDs were prepared via the solvent evaporation method, characterized by a range of techniques, and investigated with respect to permeability of human colorectal adenocarcinoma cell line (Caco-2) cells monolayers and pharmacokinetics, with comparisons made to the physical mixture and the pure drug. Key findings The (UA-choline)-Polyethylcaprolactam—polyvinyl acetate—polyethylene glycol grafted copolymer (Soluplus)-Vitamin E polyethylene glycol succinate (TPGS) ASD demonstrated superior dissolution properties compared to the corresponding binary solid dispersions and ternary solid dispersions (P< .05). The permeability studies of Caco-2 cell monolayers revealed that the ASD exhibited moderate permeability, with an efflux rate that was significantly lower than that of the UA raw material (P< .05). Pharmacokinetic studies in rats demonstrated that the oral bioavailability of the ASD was 19.0 times higher than that of UA (P< .01).
Conclusions
The research indicated that the multielement ASD could be employed as an efficacious drug delivery system for UA. Furthermore, the Soluplus/TPGS/choline combination represents a promising candidate for the fabrication of ASDs that can load weakly acidic and poorly soluble drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, People's Republic of China.
- School of Pharmacy, Shanghai University of Medicine and Health Sciences, 369 Tianxiong Road, Shanghai 201318, People's Republic of China.
ORCID-Profile: Tingting Zhao
Zitieren
APA
Zhao, T., Gu, C., Qi, J., Liu, J., Wang, Y., Chen, X., Guo, F., & Li, Y. (2024). In vitro and in vivo performance of amorphous solid dispersions of ursolic acid as a function of polymer type and excipient addition. Journal of Pharmacy and Pharmacology, 76(12), 1584-1598. https://doi.org/10.1093/jpp/rgae125
Vancouver
Zhao T, Gu C, Qi J, Liu J, Wang Y, Chen X, et al. In vitro and in vivo performance of amorphous solid dispersions of ursolic acid as a function of polymer type and excipient addition. Journal of Pharmacy and Pharmacology. 2024;76(12):1584-1598. doi:10.1093/jpp/rgae125
BibTeX
@article{Zhao2024,
author = {Zhao, Tingting and Gu, Chenming and Qi, Jianbo and Liu, Jingwen and Wang, Yajun and Chen, Xiaojing and Guo, Fujiang and Li, Yiming},
title = {In vitro and in vivo performance of amorphous solid dispersions of ursolic acid as a function of polymer type and excipient addition},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
volume = {76},
number = {12},
pages = {1584--1598},
doi = {10.1093/jpp/rgae125}
}
EUVIMED